(AIDR) Vancouver, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce its financial results for the second quarter ended June 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.
Related Questions
How much revenue did Rocket Doctor AI generate in Q2 and how does it compare to the acquisition's contribution expectations?
When will the company provide guidance on future revenue growth and profitability post‑acquisition?
What is the anticipated impact of the first revenue run‑rate on the stock’s valuation relative to peers in the AI health sector?